Abstract:When a Zika virus-infected mosquito bites a person, mosquito saliva is injected into the skin along with the virus. Molecules in this saliva can make virus infection more severe by changing the immune system to make the skin a better place for the virus to replicate. We identified a molecule that activates immune cells, called neutrophils, to recruit other immune cells, called macrophages, that the virus can infect. We named this molecule neutrophil-stimulating factor 1 (NeSt1). When we used antibodies to block NeSt1 in mice and then allowed Zika virus-infected mosquitoes to feed on these mice, they survived much better than mice that do not have antibodies against NeSt1. These findings give us more information about how mosquito saliva enhances virus infection, and it is possible that a vaccine against NeSt1 might protect people against severe Zika virus infection. ABSTRACT Saliva from the mosquito vector of flaviviruses is capable of changing the local immune environment, leading to an increase in flavivirus-susceptible cells at the infected bite site. In addition, an antibody response to specific salivary gland (SG) components changes the pathogenesis of flaviviruses in human populations. To investigate whether antigenic SG proteins are capable of enhancing infection with Zika virus (ZIKV), a reemerging flavivirus primarily transmitted by the Aedes aegypti mosquito, we screened for antigenic SG proteins using a yeast display library and demonstrate that a previously undescribed SG protein we term neutrophil stimulating factor 1 (NeSt1) activates primary mouse neutrophils ex vivo. Passive immunization against NeSt1 decreases pro-interleukin-1β and CXCL2 expression, prevents macrophages from infiltrating the bite site, protects susceptible IFNAR−/− IFNGR–/– (AG129) mice from early ZIKV replication, and ameliorates virus-induced pathogenesis. These findings indicate that NeSt1 stimulates neutrophils at the mosquito bite site to change the immune microenvironment, allowing a higher level of early viral replication and enhancing ZIKV pathogenesis. IMPORTANCE When a Zika virus-infected mosquito bites a person, mosquito saliva is injected into the skin along with the virus. Molecules in this saliva can make virus infection more severe by changing the immune system to make the skin a better place for the virus to replicate. We identified a molecule that activates immune cells, called neutrophils, to recruit other immune cells, called macrophages, that the virus can infect. We named this molecule neutrophil-stimulating factor 1 (NeSt1). When we used antibodies to block NeSt1 in mice and then allowed Zika virus-infected mosquitoes to feed on these mice, they survived much better than mice that do not have antibodies against NeSt1. These findings give us more information about how mosquito saliva enhances virus infection, and it is possible that a vaccine against NeSt1 might protect people against severe Zika virus infection.

Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes

A Mutation-Mediated Evolutionary Adaptation of Zika Virus in Mosquito and Mammalian Host.

An accumulated mutation gained in mosquito cells enhances Zika virus virulence and fitness in mice

A Zika virus mutation enhances transmission potential and confers escape from protective dengue virus immunity

Pathogenicity and Structural Basis of Zika Variants with Glycan Loop Deletions in the Envelope Protein

Aedes Mosquitoes Acquire and Transmit Zika Virus by Breeding in Contaminated Aquatic Environments.

Aedes aegypti NeSt1 Protein Enhances Zika Virus Pathogenesis by Activating Neutrophils

A Single Amino Acid Substitution in the Capsid Protein of Zika Virus Contributes to a Neurovirulent Phenotype.

Characterization of m<SUP>6</SUP>A modifications in the contemporary Zika virus genome and host cellular transcripts

Susceptibility and Interactions Between Aedes Mosquitoes and Zika Viruses

A mosquito salivary protein promotes flavivirus transmission by activation of autophagy

Ubiquitination of NS1 Confers Differential Adaptation of Zika Virus in Mammalian Hosts and Mosquito Vectors

Neighboring mutation‐mediated enhancement of dengue virus infectivity and spread

The NS1 protein of contemporary West African Zika virus potentiates viral replication and reduces innate immune activation

Host-adaptive mutations in Chikungunya virus genome

Syncytial and Congregative Effects of Dengue and Zika Viruses on the Aedes Albopictus Cell Line Differ among the Viral Strains

An evolutionarily conserved ubiquitin ligase drives infection and transmission of flaviviruses

A mosquito salivary protein-driven influx of myeloid cells facilitates flavivirus transmission

Biased virus transmission following sequential coinfection of Aedes aegypti with dengue and Zika viruses

The NS1 protein of contemporary West African Zika virus is efficient to increase cellular permissiveness to virus replication

Salivary factor LTRIN from Aedes aegypti facilitates the transmission of Zika virus by interfering with the lymphotoxin-β receptor